http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-103309-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7c35f3a3c112c482bcfa47356c4f80c
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-726
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737
filingDate 2008-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f12c75564e91d97242c1f3164cc67727
publicationDate 2013-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-103309-C2
titleOfInvention ORAL PHARMACEUTICAL COMPOSITION THAT CONTAINS Glucosamine Sulfate, Chondroitin Sulfate and Ibuprofen
abstract The invention relates to the medical field, in particular to drugs for internal use for the treatment of degenerative-dystrophic diseases of the joints of the extremities and intervertebral discs. The oral pharmaceutical composition comprises a chondroitin sulfate salt, a glucosamine sulfate salt, ibuprofen and excipients.
priorityDate 2007-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68011877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID427918928
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415712569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24766

Total number of triples: 19.